MedPointe

Leading specialty pharmaceuticals company focusing on therapeutics to treat allergic & respiratory diseases and pain

MedPointe was a fast-growing pharmaceutical company focusing on developing and commercializing a broad portfolio of therapeutics. The company’s products were focused on the Allergy / Respiratory and Pain therapeutic areas, and included leading brands such as Astelin for allergic and non-allergic rhinitis and Optivar for allergic conjunctivitis. In 2006, MedPointe generated $252M in sales (>20% annual growth), and Meda purchased MedPointe in 2007 to expand operations into the US.

Status

Acquired by Meda AB

Year of Investment

2001

Strategy

Growth Buyout

Subsector

Specialty Pharmaceuticals

Location

Somerset, New Jersey